| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Madrigal Pharmaceuticals, Inc. (MDGL) have been net sellers, shedding 12,247 shares worth roughly $6.6M on balance.
MDGL sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.95M | - | - | |
| Dir | 452.7K | - | - | |
| CEO | 197.7K | $108.04M | - | |
| Dir | 187.2K | $99.04M | - | |
| Dir | 22.5K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | Friedman Paul A | Director | Sale+OE10b5-1 | 280 | $551.24 | $154,347.59 | -0.1% | +2.0% | - | |
| Dec 10, 2025 | Friedman Paul A | Director | Sale+OE10b5-1 | 24,800 | $552.18 | $13,694,157.83 | -11.7% | -21.7% | - | |
| Dec 10, 2025 | Taub Rebecca | Director | Sale+OE10b5-1 | 18,650 | $552.15 | $10,297,572.90 | -3.9% | -21.7% | - | |
| Dec 4, 2025 | Sibold William John | President and CEO | Sale+OE | 2,400 | $575.34 | $1,380,816.00 | -1.6% | -25.8% | - | |
| Dec 2, 2025 | Dier Mardi70 | EVP and CFO | Sale+OE10b5-1 | 4,173 | $578.34 | $2,413,416.41 | -28.6% | -24.0% | - | |
| Nov 21, 2025 | Huntsman Carole | Chief Commercial Officer | Sell10b5-1 | 1,958 | $553.11 | $1,082,986.25 | -16.3% | -20.3% | - | |
| Nov 13, 2025 | Levy Richard S | Director | Sale+OE10b5-1 | 8,500 | $520.96 | $4,428,197.57 | -28.6% | -6.6% | - | |
| Nov 5, 2025 | Bate Kenneth | Director | Sale+OE | 16,575 | $484.30 | $8,027,354.15 | -86.3% | +1.4% | - | |
| Sep 9, 2025 | Sibold William John | President and CEO | Sell | 7,279 | $445.63 | $3,243,740.77 | -6.6% | +26.7% | +21.8% | |
| Aug 21, 2025 | Sibold William John | President and CEO | Sell10b5-1 | 7,616 | $400.18 | $3,047,756.37 | -6.5% | +36.5% | +26.9% |